Given the recent reports describing implications of human LH2 and its upregulated enzymatic activity in metastatic spreading of numerous solid tumors13, our full-length structures of self-inhibited human LH3 constitute a valid template for structure-based drug discovery campaigns aiming at blocking unwanted collagen lysine hydroxylation in tumor microenvironments. This evidence concerns the gene PLOD2 and neoplasm.